BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 16873772)

  • 1. Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hypertensive US Adults With Albuminuria.
    Chu CD; Powe NR; McCulloch CE; Banerjee T; Crews DC; Saran R; Bragg-Gresham J; Morgenstern H; Pavkov ME; Saydah SH; Tuot DS;
    Hypertension; 2021 Jan; 77(1):94-102. PubMed ID: 33190561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002.
    Rosen AB
    J Gen Intern Med; 2006 Apr; 21(4):315-9. PubMed ID: 16686805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of Care for Patients With Chronic Kidney Disease in the Primary Care Setting: A Retrospective Cohort Study From Ontario, Canada.
    Nash DM; Brimble S; Markle-Reid M; McArthur E; Tu K; Nesrallah GE; Grill A; Garg AX
    Can J Kidney Health Dis; 2017; 4():2054358117703059. PubMed ID: 28616249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular protection in patients with diabetes admitted for vascular surgery in a canadian tertiary care hospital: pilot study.
    Sunderland M; De Jong M; Bates D
    Can J Hosp Pharm; 2013 Jul; 66(4):227-32. PubMed ID: 23950606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges perceived by primary care providers to educating patients about chronic kidney disease.
    Greer RC; Crews DC; Boulware LE
    J Ren Care; 2012 Dec; 38(4):174-81. PubMed ID: 23176576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of primary care physicians' use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions.
    Greer RC; Powe NR; Jaar BG; Troll MU; Boulware LE
    BMC Nephrol; 2011 Jan; 12():1. PubMed ID: 21235763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical testing patterns and cost implications of variation in the evaluation of CKD among US physicians.
    Charles RF; Powe NR; Jaar BG; Troll MU; Parekh RS; Boulware LE
    Am J Kidney Dis; 2009 Aug; 54(2):227-37. PubMed ID: 19371991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who is tested for diabetic kidney disease and who initiates treatment? The Translating Research Into Action For Diabetes (TRIAD) Study.
    Johnson SL; Tierney EF; Onyemere KU; Tseng CW; Safford MM; Karter AJ; Ferrara A; Duru OK; Brown AF; Narayan KM; Thompson TJ; Herman WH
    Diabetes Care; 2006 Aug; 29(8):1733-8. PubMed ID: 16873772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification.
    Maahs DM; Snell-Bergeon JK; Kinney GL; Wadwa RP; Garg S; Ogden LG; Rewers M
    J Diabetes Complications; 2007; 21(5):273-9. PubMed ID: 17825750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
    Bleyer AJ; Sedor JR; Freedman BI; O'Brien A; Russell GB; Graley J; Schelling JR
    Am J Kidney Dis; 2008 Jan; 51(1):29-37. PubMed ID: 18155530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis.
    Jennings DL; Kalus JS; Coleman CI; Manierski C; Yee J
    Diabet Med; 2007 May; 24(5):486-93. PubMed ID: 17367311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients.
    Hillebrand U; Suwelack BM; Loley K; Lang D; Reuter S; Amler S; Pavenstädt H; Hausberg M; Büssemaker E
    Transpl Int; 2009 Nov; 22(11):1073-80. PubMed ID: 19624495
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.